Cyclacel Pharmaceuticals, Inc. Quarterly Depreciation in USD from Q1 2015 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Cyclacel Pharmaceuticals, Inc. quarterly/annual Depreciation history and growth rate from Q1 2015 to Q1 2024.
  • Cyclacel Pharmaceuticals, Inc. Depreciation for the quarter ending March 31, 2024 was $2K, a 75% decline year-over-year.
  • Cyclacel Pharmaceuticals, Inc. annual Depreciation for 2023 was $31K, a 3.13% decline from 2022.
  • Cyclacel Pharmaceuticals, Inc. annual Depreciation for 2022 was $32K, a 25.6% decline from 2021.
  • Cyclacel Pharmaceuticals, Inc. annual Depreciation for 2021 was $43K, a 115% increase from 2020.
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $2K -$6K -75% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-14
Q1 2023 $8K -$1K -11.1% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-14
Q1 2022 $9K $0 0% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q1 2021 $9K +$4K +80% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q1 2020 $5K -$1K -16.7% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-14
Q1 2019 $6K -$1K -14.3% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-12
Q1 2018 $7K -$2K -22.2% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-14
Q1 2017 $9K -$33K -78.6% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-14
Q1 2016 $42K -$10K -19.2% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-12
Q1 2015 $52K Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.